What vivola does

vivola株式会社 (vivola Inc.) is a Tokyo-based healthtech company founded in May 2020 by CEO Yukari Tsunoda, focused on improving fertility treatment outcomes through data analytics. The company operates a portfolio of five interconnected products: vivola-Insights (a subscription-based clinical information portal for medical professionals), vivola-Analytics (a predictive analytics tool that forecasts implantation and pregnancy outcomes from patient medical data), vivola-RWD (anonymized real-world data provision and analysis for pharmaceutical companies), Cocoromi (a patient-facing mobile app for visualizing treatment data), and a clinic marketing support service. Its core technology leverages hundreds of thousands of accumulated fertility treatment cycles to support clinical decision-making and personalized medicine.

The company serves two primary customer segments: fertility treatment clinics and medical institutions (vertical healthcare providers seeking data-driven decision support) and pharmaceutical companies (seeking real-world evidence for drug development), with a secondary patient segment addressed through the Cocoromi app. Revenue is generated through subscription-based services (clinical information portal, analytics tools) and professional services (RWD analysis for pharma, marketing support for clinics), with pricing handled on a quote basis. Go-to-market is direct enterprise field sales supported by inside sales, complemented by monthly webinars, conference participation, and PR/media coverage in outlets such as METI Journal and Business Insider Japan. Total disclosed funding is approximately $278K across two seed rounds (ANRI/Deepcore in 2021, Global Brain in 2022), and the company operates with 1-10 employees out of offices in Shibuya and Toranomon (WeWork), Tokyo.

Name

vivola

Legal name

vivola株式会社

Website

https://vivola.jp

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

vivola is a Tokyo-based healthtech company founded in 2020 that provides data analytics, real-world data services, and patient apps for Japan's fertility treatment market, serving fertility clinics, pharmaceutical companies, and patients through five integrated products.

Ownership category

akta.pro rank

Product category

Fertility Treatment Data Analytics

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation) (HLALAHAA)

akta.pro secondary industries

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD), Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ)

Keywords

• Fertility treatment analytics
• Clinical decision support
• Real-world data services
• Healthcare predictive analytics
• Medical EMR data processing

Headquarters

HQ city

Akasaka

HQ country

Japan

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Data Analytics Services for Fertility Treatment: Provides data analysis tools to fertility treatment clinics and conducts Real World Data (RWD) analysis for pharmaceutical companies using treatment cycle data.
2. Clinical Information Website: Operation of membership-based clinical information site (vivola-Insights) providing fertility treatment information to healthcare providers.
3. Marketing Support Services: Marketing support services for fertility treatment clinics.
4. Personnel Dispatch / Staffing: Healthcare-related personnel dispatch services.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

vivola develops and operates a fertility treatment data platform composed of five offerings: a membership-based clinical information portal for clinicians (vivola-Insights), a predictive analytics tool for personalized fertility treatment decisions (vivola-Analytics), an anonymized real-world data service for pharmaceutical research (vivola-RWD), a patient-facing mobile app visualizing treatment data (Cocoromi), and marketing support services for fertility clinics. The underlying asset is a proprietary dataset of hundreds of thousands of fertility treatment cycles used to generate clinical decision support, predictive insights, and pharma-grade evidence.

Product overview

vivola is a healthtech company offering a platform of fertility treatment data solutions. The portfolio consists of five interconnected products: vivola-Insights (a subscription-based clinical information portal for medical professionals), vivola-Analytics (a predictive analytics tool for personalized treatment), vivola-RWD (real-world data anonymization and analysis services), Cocoromi (a patient-facing data visualization app), and vivola-マーケティング (clinic marketing support services). Together, these products serve patients, fertility clinics, and pharmaceutical companies by leveraging treatment data to improve clinical outcomes and decision-making.

Differentiator

Problem solved

Functional benefit

Brands

• vivola-Insights: Subscription-based clinical information website specialized for fertility treatment
• vivola-Analytics
• vivola-RWD
• Cocoromi
• vivola-マーケティング

Products and services

• vivola-Insights Subscription-based membership clinical information website specialized for fertility treatment, providing clinically useful information, resources, and regular webinars to healthcare providers.
• vivola-Analytics Analytical tool that enables personalized fertility treatment by predicting implantation and pregnancy possibilities based on patient data including disease, examination values, and prescriptions sourced from electronic medical records.
• vivola-RWD Anonymized data provision and analysis service for fertility treatment, providing real-world data to pharmaceutical companies for clinical research and drug development.
• Cocoromi Patient-facing mobile application that visualizes fertility treatment data, helping patients track and understand their treatment progress and supporting informed shared decision-making with clinicians.
• vivola-marketing Marketing support services tailored for fertility treatment clinics, designed to improve patient acquisition and engagement for clinic operators.

Quantifiable outcome

• Improved treatment outcomes and patient satisfaction through data-driven personalized medicine
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Carrot Fertility: Global fertility benefits and care navigation platform serving employers and patients. Comparable to vivola in targeting the fertility ecosystem with data-driven tools, though more focused on benefits administration.
• Kindbody: US-based fertility clinic and benefits platform combining in-person care with proprietary data and analytics. Directly comparable to vivola as a vertically integrated fertility data platform serving clinics, employers, and patients.
• Apricity: UK and EU fertility virtual care platform combining clinical decision support with patient-facing digital tools. Highly comparable to vivola's combination of clinic-side analytics and patient-facing Cocoromi app.
• Univfy: US fertility prediction analytics company using patient data to predict IVF success probabilities. Closest direct comparison to vivola-Analytics's implantation and pregnancy prediction models.
• Natural Cycles: Data-driven fertility and reproductive health platform combining consumer apps with clinical analytics. Comparable to vivola's Cocoromi patient app plus vivola-Analytics approach to data-driven reproductive health.

Broad incumbents

• Progyny: Public US fertility benefits leader with deep clinical data infrastructure. Comparable to vivola's clinic-pharma-patient platform at scale, representing a potential exit trajectory or competitive benchmark.
• Maven Clinic: Global women's and family health virtual care platform with strong data and analytics layer. Comparable to vivola as a multi-stakeholder fertility and women's health platform with employer and pharma channels.
• JMDC: Japan's leading health data analytics company serving insurers, pharma, and providers. Strongly comparable as a domestic incumbent in Japanese health RWD; vivola board member Sugita was previously JMDC's COO.

Emerging players

• Medley: Japanese digital health company serving healthcare providers and patients across multiple verticals. Comparable to vivola as a fellow Japanese healthtech serving clinics with digital tools and recurring revenue models.
• Ubie: Japanese AI healthtech platform serving patients and providers with symptom checking and clinical decision support. Comparable to vivola as a Japanese healthtech using data to inform clinical decisions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/cocoromi_vivola
• Facebookfacebook.com/vivola.jp

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about vivola